Literature DB >> 15718832

Ocular toxicity of intravitreal indocyanine green.

San-Ni Cheng1, Te-Cheng Yang, Jau-Der Ho, Jiunn Feng Hwang, Cheng-Kuo Cheng.   

Abstract

We report 6 cases of indocyanine green (ICG)-related ocular toxicity after intravitreal ICG usage. Five cases had preoperative diagnosis of macular hole, 1 case had preoperative rhegmatogenous retinal detachment complicated with proliferative vitreoretinopathy. All cases received vitrectomy, ICG-assisted internal limiting membrane (ILM) peeling and air-fluid exchange. All eyes had residual ICG left at the end of surgery. Patients were followed up with indirect ophthalmoscopy, visual acuity, color fundus photography, fluorescein angiography, and ocular coherence tomography. Circular foveal retinal pigment epithelium atrophy larger than the area of macular hole and surrounding cuff was noted in 4 of 5 cases with preoperative macular hole. The other eye with preoperative diagnosis of macular hole had shallow anterior chamber and low intraocular pressure lasting for 1 week postoperatively. Diffuse retinal pigment epithelial atrophy was noted in the eye with preoperative proliferative vitreoretinopathy. Four eyes demonstrated optic atrophy postoperatively. Ocular toxicity caused by ICG may present as pigment epithelial atrophy, which is characteristically larger than the previous area of macular hole and surrounding cuff. Disc atrophy, retinal toxicity, and ocular hypotony were also observed in some cases. To prevent toxicity, residual ICG and ICG-stained ILM must be removed as completely as possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718832     DOI: 10.1089/jop.2005.21.85

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  11 in total

Review 1.  [Vital dyes in vitreoretinal surgery. Current application concepts].

Authors:  C Haritoglou; S Thaler; A Kampik; F Schüttauf
Journal:  Ophthalmologe       Date:  2009-01       Impact factor: 1.059

2.  [Visual loss after pars plana vitrectomy with membrane peeling].

Authors:  M Schmidt; N Schrage; C Clemens; N Eter
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

3.  Investigating retinal toxicity of a lutein-based dye in a model of isolated and perfused bovine retina.

Authors:  Sebastian Mueller; Carlo Krupp; Sven Schnichels; Johanna Hofmann; Martin Spitzer; Karl Ulrich Bartz-Schmidt; Peter Szurman; Kai Januschowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-02-20       Impact factor: 3.117

4.  [Staining techniques in macular surgery].

Authors:  C Haritoglou; A Kampik
Journal:  Ophthalmologe       Date:  2006-11       Impact factor: 1.059

5.  Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin.

Authors:  Kai Januschowski; Sebastian Mueller; Martin S Spitzer; Charlotte Schramm; Deshka Doycheva; Karl-Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-03-28       Impact factor: 3.117

6.  The effects of the intraocular dye brilliant blue G (BBG) mixed with varying concentrations of glucose on retinal function in an isolated perfused vertebrate retina.

Authors:  Kai Januschowski; Sebastian Mueller; Martin S Spitzer; Matthias Lueke; Karl-Ulrich Bartz-Schmidt; Peter Szurman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-19       Impact factor: 3.117

7.  Testing the effects of the dye acid violet-17 on retinal function for an intraocular application in vitreo-retinal surgery.

Authors:  Aysegül Tura; Aizhan Alt; Christos Haritoglou; Carsten H Meyer; Toni Schneider; Salvatore Grisanti; Julia Lüke; Matthias Lüke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-14       Impact factor: 3.117

8.  Biocompatibility of the vital dye Acid Violet-17 on retinal pigment epithelial cells.

Authors:  Ayşegül Tura; Aizhan Alt; Julia Lüke; Salvatore Grisanti; Christos Haritoglou; Carsten H Meyer; Khaled Nassar; Matthias Lüke
Journal:  Clin Ophthalmol       Date:  2016-07-29

9.  Microincision vitrectomy surgery in vitreomacular traction syndrome of retinitis pigmentosa patients.

Authors:  Enzo Maria Vingolo; Emanuele Gerace; Stefano Valente; Leopoldo Spadea; Marcella Nebbioso
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

Review 10.  Optimal management of idiopathic macular holes.

Authors:  Haifa A Madi; Ibrahim Masri; David H Steel
Journal:  Clin Ophthalmol       Date:  2016-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.